Meeting Coverage
MHNCS
Multidisciplinary Head and Neck Cancer Symposium
Latest MHNCS Meeting Coverage
SCOTTSDALE, Ariz. -- Chemoradiation plus the targeted agent zalutumumab failed to improve disease control or survival in patients with squamous cell head and neck cancer, a finding that leads this roundup of news from the Multidisciplinary Head and Neck Cancer Symposium.
February 22, 2014
PHOENIX -- Patients with head and neck cancer had substantial sparing of oral mucosa when they used custom-made dental stents to shield normal tissue from radiation therapy, data from a small clinical series showed.
January 31, 2012
PHOENIX -- Osteoradionecrosis of the jaw occurred more than twice as often in patients treated for oral cancer as reported in the literature, according to a population-based study.
January 30, 2012
Latest Oncology/Hematology Meeting Coverage
-
AHNS: American Head & Neck Society
July 2023
-
ASCO Future Focus: Immunotherapy: Future Focus from the American Society of Clinical Oncology
June 2023
-
ASCO Video Pearls: Immunotherapy: Video Pearls from the American Society of Clinical Oncology
June 2023
-
ASCO Video Pearls: Renal Cell Carcinoma: Video Pearls from the American Society of Clinical Oncology
June 2023